Jeff Garro
Stock Analyst at Stephens & Co.
(1.03)
# 3,563
Out of 4,829 analysts
49
Total ratings
30.3%
Success rate
-13.21%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $24.81 | +12.86% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $237.05 | +18.12% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $4.13 | +21.07% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $11.98 | +41.90% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $9.05 | +32.60% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $25.02 | +3.92% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.69 | +35.50% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $59.19 | -7.08% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $9.99 | -44.94% | 3 | Dec 20, 2024 | |
| IQV IQVIA Holdings | Initiates: Overweight | $250 | $148.99 | +67.80% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $15.31 | +11.04% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $30.02 | +29.91% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $25.62 | +9.29% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.11 | +293.81% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $15.12 | +32.32% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.64 | +7.14% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.67 | +12.36% | 3 | May 6, 2022 |
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $24.81
Upside: +12.86%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $237.05
Upside: +18.12%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.13
Upside: +21.07%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $11.98
Upside: +41.90%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.05
Upside: +32.60%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $25.02
Upside: +3.92%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.69
Upside: +35.50%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $59.19
Upside: -7.08%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $9.99
Upside: -44.94%
IQVIA Holdings
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $148.99
Upside: +67.80%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $15.31
Upside: +11.04%
Nov 15, 2024
Initiates: Overweight
Price Target: $39
Current: $30.02
Upside: +29.91%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $25.62
Upside: +9.29%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.11
Upside: +293.81%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $15.12
Upside: +32.32%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.64
Upside: +7.14%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.67
Upside: +12.36%